Self-Assembled Cylindrical Capsule
ture, and the mixture was stirred for overnight at room
temperature. The resulting mixture was evaporated to dryness
under reduced pressure. The residue was dissolved in ethyl
acetate. After removal of an amount of insoluble materials by
filtration, the filtrate was then washed with 10% aqueous citric
acid, saturated aqueous sodium chloride, and 4% aqueous
sodium hydrogen carbonate in this sequence. After being dried
(MgSO4), the solution was evaporated to dryness under
reduced pressure. The residue was chromatographed on a
column of silica gel with ethyl acetate-hexane as eluant. The
product fraction was collected and dried in vacuo. The crude
product was purified by gel filtration chromatography on a
column of Sephadex LH-20 with methanol-chloroform (1:1 v/v)
as eluant. The product fraction was collected and dried in
vacuo.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e m eth yl ester (2):
prepared following the general procedure B on a 144 mM scale
of L-alanine methyl ester hydrochoride. 1H NMR (600 MHz,
CDCl3, 296 K) δH 1.32 (3H, t, J 7.2 Hz, CHCH3), 1.38 [9H, s,
(CH3)3CO], 3.68 (3H, s, OCH3), 4.26(1H, m, CHCH3), 5.12 (1H,
m, NH). Rf (K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v)
0.74.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e eth yl ester (3): pre-
pared following the general procedure A on a 106 mM scale of
N-R-tert-butoxycarbonyl-L-alanine and ethanol. 1H NMR (600
MHz, CDCl3, 296 K) δH 1.26 (3H, t, J 7.1 Hz, CH2CH3), 1.37
(3H, d, J 7.2 Hz, CHCH3), 1.43 [9H, s, (CH3)3CO], 4.18 (2H, q,
J 7.1 Hz, CH2CH3), 4.27 (1H, m, CHCH3), 5.17 (1H, m, NH).
Rf (K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.74.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e n -p r op yl ester (4):
prepared following the general procedure A on a 106 mM scale
of N-R-tert-butoxycarbonyl-L-alanine and 1-propanol. 1H NMR
(600 MHz, CDCl3, 296 K) δH 0.88 (3H, t, J 7.1 Hz, CH2CH3),
1.32 (3H, d, J 7.2 Hz, CHCH3), 1.37 [9H, s, (CH3)3CO], 1.60
(2H, q, J 7.1 Hz, CH2CH2CH3), 4.04 (2H, m, CH2CH2CH3), 4.23
(1H, m, CHCH3), 5.15 (1H, m, NH). Rf (K6F Silica Gel; CHCl3:
CH3OH:AcOH ) 95:5:3 v/v) 0.74.
CH2CH3), 1.40 [9H, s, (CH3)3CO], 1.4-1.8 (8H, m, cyclic-CH2),
4.22 (1H, m, OCH), 5.08 (1H, m, CHCH3), 5.18 (1H, m, NH).
Rf (K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.69.
N-r-ter t-Bu t oxyca r b on yl-L-a la n in e cycloh exyl est er
(10): prepared following the general procedure A on a 106 mM
scale of N-R-tert-butoxycarbonyl-L-alanine and cyclohexanol.
1
1H NMR (600 MHz, CDCl3, 296 K) H 1.36 (3H, t, J 7.2 Hz,
CH2CH3), 1.44 [9H, s, (CH3)3CO], 1.3-1.8 (10H, m, cyclic-CH2),
4.27 (1H, m, OCH), 4.80 (1H, m, CHCH3), 5.08 (1H, m, NH).
Rf (K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.69.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e cycloh ep tyl ester
(11): prepared following the general procedure A on a 106 mM
scale of N-R-tert-butoxycarbonyl-L-alanine and cycloheptanol.
1H NMR (600 MHz, CDCl3, 296 K) δH 1.35 (3H, t, J 7.2 Hz,
CH2CH3), 1.43 [9H, s, (CH3)3CO], 1.3-1.8 (12H, m, cyclic-CH2),
4.24 (1H, m, OCH), 4.96 (1H, m, CHCH3), 5.08 (1H, m, NH).
Rf (K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.72.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e ben zyl ester (12):
prepared following the general procedure B on a 114 mM scale
of L-alanine benzyl ester p-tosylate. 1H NMR (600 MHz, CDCl3,
296 K) δH 1.33 (3H, d, J 7.0 Hz, CHCH3), 1.48 [9H, s, (CH3)3-
COCONH], 4.4 (1H, m, CHCH2), 5.1 (1H, m, NH), 5.2 (2H, m,
CH2), 7.39 (5H, m, Ar-H). Rf (K6F Silica Gel; CHCl3:CH3OH:
AcOH ) 95:5:3 v/v) 0.82.
N-r-ter t-Bu toxyca r bon yl-â-a la n in e m eth yl ester (13):
prepared following the general procedure A on a 106 mM scale
1
of N-R-tert-butoxycarbonyl-â-alanine and methanol. H NMR
(600 MHz, CDCl3, 296 K) δH 1.42 [9H, s, (CH3)3CO], 2.52 (2H,
t, J 6.0 Hz, NHCH2CH2), 3.39 (2H, m, NHCH2CH2), 3.69 (3H,
s, OCH3), 5.04 (1H, m, NH). Rf (K6F Silica Gel; CHCl3:CH3-
OH:AcOH ) 95:5:3 v/v) 0.68.
N-r-ter t-Bu t oxyca r b on yl-â-a la n in e et h yl est er (14):
prepared following the general procedure A on a 106 mM scale
of N-R-tert-butoxycarbonyl-â-alanine and ethanol. 1H NMR
(600 MHz, CDCl3, 296 K) δH 1.26 (3H, t, J 7.2 Hz, CH2CH3),
1.42 [9H, s, (CH3)3CO], 2.51 (2H, t, J 6.0 Hz, NHCH2CH2), 3.39
(2H, m, NHCH2CH2), 4.15 (2H, q, J 7.2 Hz, OCH2CH3), 5.03
(1H, m, NH). Rf (K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:
5:3 v/v) 0.68.
N-r-ter t-Bu toxyca r bon yl-â-a la n in e n -p r op yl ester (15):
prepared following the general procedure A on a 106 mM scale
of N-R-tert-butoxycarbonyl-â-alanine and 1-propanol. 1H NMR
(600 MHz, CDCl3, 296 K) δH 0.88 (3H, t, J 7.3 Hz, CH2CH3),
1.37 [9H, s, (CH3)3CO], 1.66 (2H, m, OCH2CH2CH3), 2.47 (2H,
t, J 6.4 Hz, NHCH2CH2), 3.33 (2H, m, NHCH2CH2), 4.00 (2H,
q, J 6.4 Hz, OCH2CH2CH3), 5.16 (1H, m, NH). Rf (K6F Silica
Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.70.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e n -bu tyl ester (5):
prepared following the general procedure A on a 106 mM scale
1
of N-R-tert-butoxycarbonyl-L-alanine and 1-butanol. H NMR
(600 MHz, CDCl3, 296 K) δH 0.94 (3H, t, J 7.1 Hz, CH2CH3),
1.39 (3H, d, J 7.2 Hz, CHCH3), 1.4 [2H, m, O(CH2)2CH2CH3],
1.45 [9H, s, (CH3)3CO], 1.64 (2H, m, OCH2CH2CH2CH3), 4.16
(2H, m, OCH2CH2), 4.3 (1H, m, CHCH3), 5.06 (1H, m, NH). Rf
(K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.74.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e n -p en tyl ester (6):
prepared following the general procedure A on a 106 mM scale
of N-R-tert-butoxycarbonyl-L-alanine and 1-pentanol. 1H NMR
(600 MHz, CDCl3, 296 K) δH 0.88 (3H, t, J 7.1 Hz, CH2CH3),
1.29-1.31 [7H, O(CH2)2(CH2)2CH3, CHCH3], 1.45 [9H, s,
(CH3)3CO], 1.62 [2H, m, OCH2CH2(CH2)2CH3], 4.11 [2H, m,
OCH2(CH2)3CH3], 4.27 (1H, m, CHCH3), 5.09 (1H, m, NH). Rf
(K6F Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.74.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e n -h exyl ester (7):
prepared following the general procedure A on a 106 mM scale
N-r-ter t-Bu toxyca r bon yl-â-a la n in e n -bu tyl ester (16):
prepared following the general procedure A on a 106 mM scale
1
of N-R-tert-butoxycarbonyl-â-alanine and 1-butanol. H NMR
(600 MHz, CDCl3, 296 K) δH 0.88 (3H, t, J 7.3 Hz, CH2CH3),
1.30 [9H, s, (CH3)3CO], 1.2-1.5 [4H, m, OCH2(CH2)2CH3], 2.40
(2H, t, J 6.4 Hz, NHCH2CH2), 3.25 (2H, m, NHCH2CH2), 3.97
[2H, q, J 6.4 Hz, OCH2(CH2)2CH3], 5.21 (1H, m, NH). Rf (K6F
Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.71.
1
of N-R-tert-butoxycarbonyl-L-alanine and 1-hexanol. H NMR
N-r-ter t-Bu toxyca r bon yl-â-a la n in e n -p en tyl ester (17):
prepared following the general procedure A on a 106 mM scale
of N-R-tert-butoxycarbonyl-â-alanine and 1-pentanol. 1H NMR
(600 MHz, CDCl3, 296 K) δH 0.92 (3H, t, J 7.2 Hz, CH2CH3),
1.45 [9H, s, (CH3)3CO], 1.3-1.7 [6H, m, OCH2(CH2)3CH3], 2.53
(2H, t, J 6.4 Hz, NHCH2CH2), 3.41 (2H, m, NHCH2CH2), 4.10
[2H, q, J 6.4 Hz, OCH2(CH2)3CH3], 5.09 (1H, m, NH). Rf (K6F
Silica Gel; CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.71.
N-r-ter t-Bu toxyca r bon yl-glycin e eth yl ester (18): pre-
pared following the general procedure A on a 114 mM scale
N-R-tert-butoxycarbonyl-glycine and ethanol. 1H NMR (600
MHz, CDCl3, 296 K) δH 1.22 (3H, t, J 7.1 Hz, CH2CH3), 1.39
[9H, s, (CH3)3CO], 3.84 (2H, d, J 5.4 Hz, CH2), 4.15 (2H, q, J
7.1 Hz, CH2CH3), 5.12 (1H, m, NH). Rf (K6F Silica Gel; CHCl3:
CH3OH:AcOH ) 95:5:3 v/v) 0.71.
(600 MHz, CDCl3, 296 K) δH 0.84 (3H, t, J 7.1 Hz, CH2CH3),
1.2-1.6 (11H, OCH2(CH2)4CH3, CHCH3), 1.39 [9H, s, (CH3)3-
CO], 1.59 (2H, m, OCH2CH2), 4.08 [2H, m, OCH2(CH2)4CH3],
4.24 (1H, m, CHCH3), 5.12 (1H, m, NH). Rf (K6F Silica Gel;
CHCl3:CH3OH:AcOH ) 95:5:3 v/v) 0.71.
N-r-ter t-Bu t oxyca r b on yl-L-a la n in e ter t-Bu t yl est er
(8): prepared following the general procedure B on a 110 mM
scale of L-alanine tertert-butyl ester hydrochoride. 1H NMR
(600 MHz, CDCl3, 296 K) δH 1.30 (3H, d, J 7.0 Hz, CHCH3),
1.40 [9H, s, (CH3)3COCOCH], 1.42 [9H, s, (CH3)3COCONH],
4.14 (1H, m, CH), 5.1 (1H, m, NH). Rf (K6F Silica Gel; CHCl3:
CH3OH:AcOH ) 95:5:3 v/v) 0.77.
N-r-ter t-Bu toxyca r bon yl-L-a la n in e cyclop en tyl ester
(9): prepared following the general procedure A on a 106 mM
scale of N-R-tert-butoxycarbonyl-L-alanine and cyclopentanol.
1H NMR (600 MHz, CDCl3, 296 K) δH 1.33 (3H, t, J 7.2 Hz,
N-r-ter t-Bu toxyca r bon yl-glycin e ter t-Bu tyl ester (19):
prepared following the general procedure B on a 120 mM scale
J . Org. Chem, Vol. 67, No. 24, 2002 8297